This is a preview of subscription content, log in via an institution to check access.
Reference
Kai M, et al. Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study. PLOS One 19: Jan 2024. Available from: URL: https://dx.doi.org/10.1371/journal.pone.0294590
Rights and permissions
About this article
Cite this article
Atezolizumab/Bevacizumab. Reactions Weekly 1992, 35 (2024). https://doi.org/10.1007/s40278-024-52768-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-52768-0